3rd Edition of Infectious Diseases World Conference 2026

Speakers - 2024

Mady Ndiaye, Infectious Diseases World Conference, Paris

Mady Ndiaye

Mady Ndiaye

  • Designation: University Cheikh Anta Diop de Dakar
  • Country: Senegal
  • Title: Antibiotic resistance profiles of Escherichia coli strains isolated in Senegal

Abstract

Introduction: The misuse and misprescription of antibiotic medications in humans and animals are very often the causes of resistance acquired by bacteria such as Escherichia coli. Some strains of this species of the Enterobacteriaceae family are currently developing, at the global level, an increased resistance to several families of antibiotics, hence the need to carry out very frequent surveillance studies of these resistances at the national level.

 

Material and methods - Fifty-one (51) strains of E. coli from the Bacteriology-Virology Laboratory of the National University Hospital of Fann and isolated between January 1 and February 28, 2023, are the subject of this study.

The pathological products from which these strains have been isolated are: urine, blood, pus, and vaginal and urethral swabs. These strains were isolated based on the morphological, biochemical and cultural characteristics of Escherichia coli.

The antibiogram was performed with the agar diffusion technique according to the recommendations of the CA-SFM (Antibiogram Committee of the French Society of Microbiology).

 

Results

The antibiogram of Beta-lactam shows very high resistance to amoxicillin (84.31%), ticarcillin (87.50%) and amoxicillin/clavulanic acid (64.71%).

Cephalosporins, in particular cefotaxime and cefepime, have resistance of 50% and 54.90%, respectively.

51.11% of the E. coli  strains in the study are resistant to aztreonam, unlike imipenema and ertapeneme, for which only 3.13% and 11.76% of the strains show resistance (Table 1).

6.12% of the strains are resistant to amikacin, 55.10% and 62.07% to levofloxacin and norfloxacin, respectively (Table 2).

 

Table1: Resistance of isolated strains to beta-lactam

 

 

Antibiotic

 

Number of strains tested

 

Critical values

 

Number of resistant strains

 

Percentage of resistant strains

 

Amoxicilline

51

19

43

84,31%

Amoxicilline / Acide clavulanique

51

19

33

64,71%

Ticarcilline

48

20-23

42

87,50%

Ticarcilline / acid clavulanique

49

20-23

40

81,63%

Céfépime

51

24-27

28

54,90%

Céfotaxime

24

17-20

12

50,00%

Aztréonam

45

28

23

51,11%

imipénéme

32

19-50

1

3,13%

Ertapénéme

51

25

6

11,76%

 

 

Table 2: Resistance of strains to aminoglycosides (quinolones and others)

 

Antibiotics

 

Number of strains tested

 

Critical values

 

Number of resistant strains

Percentage of resistant strains

 

Amikacine

49

18

3

6,12%

Tobramicine

50

16

8

16,00%

Acide nalidixique

45

14

15

33,33%

Lévofloxacine

49

19-23

27

55,10%

Norfloxacine

29

22

18

62,07%

Colistine

47

16

0

0%

Cotrimoxazole

29

11-14

23

79,31%

Fosfomycine

49

21

5

10,20%

 

 

                                   

Discussion: The study shows that 33.33% of the samples come from the neurology department, 19.05% from the thoracic and cardiovascular surgery department (CTCV) and 14.29% from the infectious and tropical diseases department (MIT).

The results for the neurology and CTCV departments could be explained by an aggravation of infections such as sepsis and by the vulnerability of patients (often immunocompromised) to the infectious and tropical diseases department.

62.75% of the E. coli strains in the study are isolated from urine. This result, similar to several national and international studies, places E. coli as the major species responsible for urinary tract infections in Senegal and worldwide. The high rates of resistance obtained with the help of antibiograms carried out on our E. coli strains show a circulation of ESBL E. coli strains at the community level.

 

Conclusion: The study reveals a circulation of ESBL E. coli strain at the community level. Thus, much more advanced molecular studies should be carried out to verify the circulation of these multidrug-resistant strains in the country's hospitals, which could, in this case, be the cause of nosocomial infections that not only require complicated therapeutic management but also participate in the spread of antibiotic-resistant bacteria. 

 

Keywords: E. coli resistance to antibiotics, Senegal